Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.45 CAD | -2.68% | -7.64% | -18.99% |
05-15 | Transcript : Oncolytics Biotech Inc. - Shareholder/Analyst Call | |
05-15 | Oncolytics Biotech Announces Preliminary Collaboration with GCAR for Inclusion of Pelareorep in Pancreatic Cancer Trial | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.99% | 82.66M | |
+64.92% | 62.59B | |
-1.85% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+13.05% | 26.21B | |
-21.96% | 19.09B | |
+4.21% | 13.08B | |
+25.74% | 12.26B | |
+27.42% | 12.05B |
- Stock Market
- Equities
- ONC Stock
- News Oncolytics Biotech Inc.
- Transcript : Oncolytics Biotech Inc., Q3 2021 Earnings Call, Nov 05, 2021